SYNTA PHARMACEUTICALS CORP - COM (SNTA)

CUSIP: 87162T206

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / COM
Total 13F shares
66,465,599
Share change
-7,087,039
Total reported value
$148,190,267
Put/Call ratio
133%
Price per share
$2.23
Number of holders
95
Value change
-$13,190,533
Number of buys
55
Number of sells
36

Quarterly Holders Quick Answers

What is CUSIP 87162T206?
CUSIP 87162T206 identifies SNTA - SYNTA PHARMACEUTICALS CORP - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SYNTA PHARMACEUTICALS CORP - COM (SNTA) as of Q2 2015

As of 30 Jun 2015, SYNTA PHARMACEUTICALS CORP - COM (SNTA) was held by 95 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 66,465,599 shares. The largest 10 holders included CAXTON CORP, JENNISON ASSOCIATES LLC, BlackRock Fund Advisors, FMR LLC, VANGUARD GROUP INC, STATE STREET CORP, NORTHERN TRUST CORP, BlackRock Institutional Trust Company, N.A., Bank of New York Mellon Corp, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 95 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.